Co-Authors
This is a "connection" page, showing publications co-authored by Anu Osinusi and Diana Brainard.
Connection Strength
0.407
-
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care. Clin Infect Dis. 2021 12 06; 73(11):e4166-e4174.
Score: 0.061
-
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019. Clin Infect Dis. 2021 12 06; 73(11):e3996-e4004.
Score: 0.061
-
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. Open Forum Infect Dis. 2021 Jul; 8(7):ofab278.
Score: 0.059
-
Compassionate Use of Remdesivir in Children With Severe COVID-19. Pediatrics. 2021 05; 147(5).
Score: 0.059
-
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 09 15; 324(11):1048-1057.
Score: 0.056
-
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 11 05; 383(19):1827-1837.
Score: 0.055
-
Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020 06 11; 382(24):2327-2336.
Score: 0.055